THE SMART TRICK OF API PRODUCTS THAT NOBODY IS DISCUSSING

“The current predicament has exposed some structural weaknesses while in the EU’s medicines source chain plus a substantial dependence on non-EU nations for active pharmaceutical ingredients,” Kyriakides explained. She proposed that supply chain concerns be resolved within an EU pharmaceutical tactic predicted for being introduced by the tip